Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 190
Selected: 0
NCT IDTitle
NCT07498829Population Based Germline Testing for Early Detection and Prevention of Cancer
NCT00959023Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT011246823-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
NCT04648033Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours
NCT04458311Abiraterone Acetate in Combination With Tildrakizumab
NCT03145961A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
NCT03875820Phase I Trial of Defactinib and VS-6766.
NCT02973828PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
NCT02170415Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery
NCT05375591AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
NCT02388308Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT00077090Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer
NCT00140582Primary Rituximab and Maintenance
NCT02403102Imageguided Theranostics in Multiple Myeloma
NCT00002892Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
NCT05990192SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
NCT01104571Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
NCT01395121A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread
NCT00997464An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT02928432SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone
NCT02409212Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT02447549Study of Tumour Focused Radiotherapy for Bladder Cancer
NCT06975579The COherence of Scatter Identification and Exclusion Algorithm Study
NCT04359420What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol
NCT03574454Machine Learning in Myeloma Response
NCT06636526The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
NCT00079248Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT02126800Rapid Medical Donation Programme for Breast Cancer
NCT05810467The Active Surveillance Study
NCT00286117ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
NCT03740893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
NCT00787514FR in Stored Plasma
NCT00077168Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
NCT02437227Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
NCT06396754Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC
NCT03466944PUMA (Paediatric Osseous Marrow Assessment)
NCT03262311Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours
NCT01737242UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
NCT00031850Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT02296801A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
NCT00301925Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
NCT03177187Combination Study of AZD5069 and Enzalutamide.
NCT02819752PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
NCT03809377Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
NCT06470685Prophylactic Prostatectomy for Prostate Cancer (PPPC)
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients